Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.61 USD | +2.79% | +5.42% | -9.27% |
May. 14 | Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating | MT |
May. 13 | Transcript : UroGen Pharma Ltd., Q1 2024 Earnings Call, May 13, 2024 |
Financials (USD)
Sales 2024 * | 93.99M | Sales 2025 * | 149M | Capitalization | 478M |
---|---|---|---|---|---|
Net income 2024 * | -128M | Net income 2025 * | -108M | EV / Sales 2024 * | 4.15 x |
Net cash position 2024 * | 88.52M | Net cash position 2025 * | 308M | EV / Sales 2025 * | 1.14 x |
P/E ratio 2024 * |
-3.78
x | P/E ratio 2025 * |
-4.63
x | Employees | 204 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.16% |
Latest transcript on UroGen Pharma Ltd.
1 day | +2.79% | ||
1 week | +5.42% | ||
Current month | -1.52% | ||
1 month | -3.82% | ||
3 months | -26.79% | ||
6 months | +6.49% | ||
Current year | -9.27% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 61 | 19-01-02 | |
Dong Kim
DFI | Director of Finance/CFO | 47 | 21-07-31 |
Jason Smith
CMP | Compliance Officer | 52 | 20-09-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arie Belldegrun
CHM | Chairman | 74 | 12-09-30 |
Cynthia Butitta
BRD | Director/Board Member | 69 | 17-09-30 |
Fred Cohen
BRD | Director/Board Member | 67 | 17-05-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +4.49% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 13.61 | +2.79% | 300,881 |
24-05-24 | 13.24 | +3.04% | 272,413 |
24-05-23 | 12.85 | -3.46% | 255,841 |
24-05-22 | 13.31 | +0.30% | 231,128 |
24-05-21 | 13.27 | +2.79% | 224,667 |
Delayed Quote Nasdaq, May 28, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.27% | 478M | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |
- Stock Market
- Equities
- URGN Stock